|
Name |
Ergosta-7,22-dien-5,9-epoxy-(22E,24R)-6-one-3-yl acetate
|
Molecular Formula | C30H44O4 | |
IUPAC Name* |
[8-(5,6-dimethylhept-3-en-2-yl)-9,13-dimethyl-2-oxo-18-oxapentacyclo[10.5.1.01,13.04,12.05,9]octadec-3-en-16-yl]acetate
|
|
SMILES |
CC(=O)OC1CCC2(C)C3(C1)OC21CCC2(C)C(CCC2C(C)C=CC(C)C(C)C)C1=CC3=O
|
|
InChI |
InChI=1S/C30H44O4/c1-18(2)19(3)8-9-20(4)23-10-11-24-25-16-26(32)30-17-22(33-21(5)31)12-13-28(30,7)29(25,34-30)15-14-27(23,24)6/h8-9,16,18-20,22-24H,10-15,17H2,1-7H3/b9-8+/t19-,20+,22-,23+,24?,27+,28+,29+,30-/m0/s1
|
|
InChIKey |
IMKFFAIHVGHKNV-YCAZLUJNSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 468.68 | ALogp: | 6.4 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 52.6 | Aromatic Rings: | 6 |
Heavy Atoms: | 34 | QED Weighted: | 0.346 |
Caco-2 Permeability: | -4.737 | MDCK Permeability: | 0.00001910 |
Pgp-inhibitor: | 0.942 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.024 |
30% Bioavailability (F30%): | 0.77 |
Blood-Brain-Barrier Penetration (BBB): | 0.471 | Plasma Protein Binding (PPB): | 99.26% |
Volume Distribution (VD): | 1.594 | Fu: | 1.65% |
CYP1A2-inhibitor: | 0.008 | CYP1A2-substrate: | 0.831 |
CYP2C19-inhibitor: | 0.043 | CYP2C19-substrate: | 0.973 |
CYP2C9-inhibitor: | 0.265 | CYP2C9-substrate: | 0.047 |
CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.086 |
CYP3A4-inhibitor: | 0.806 | CYP3A4-substrate: | 0.955 |
Clearance (CL): | 12.223 | Half-life (T1/2): | 0.051 |
hERG Blockers: | 0.003 | Human Hepatotoxicity (H-HT): | 0.082 |
Drug-inuced Liver Injury (DILI): | 0.423 | AMES Toxicity: | 0.733 |
Rat Oral Acute Toxicity: | 0.863 | Maximum Recommended Daily Dose: | 0.084 |
Skin Sensitization: | 0.026 | Carcinogencity: | 0.676 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.017 |
Respiratory Toxicity: | 0.943 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003053 | 0.613 | D0G8OC | 0.407 | ||||
ENC006035 | 0.613 | D06JPB | 0.395 | ||||
ENC005610 | 0.613 | D0G5CF | 0.378 | ||||
ENC004864 | 0.613 | D0N1TP | 0.296 | ||||
ENC004677 | 0.519 | D0I2SD | 0.278 | ||||
ENC002324 | 0.519 | D0Y7LD | 0.266 | ||||
ENC002665 | 0.491 | D01QUS | 0.266 | ||||
ENC006037 | 0.491 | D07BSQ | 0.266 | ||||
ENC004906 | 0.483 | D02CJX | 0.263 | ||||
ENC003120 | 0.483 | D08SVH | 0.259 |